| Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis DA Berry, S Zhou, H Higley, L Mukundan, S Fu, GH Reaman, BL Wood, ... JAMA oncology 3 (7), e170580-e170580, 2017 | 492 | 2017 |
| Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis H Tang, W Shi, S Fu, T Wang, S Zhai, Y Song, J Han Cancer medicine 7 (4), 1070-1080, 2018 | 128 | 2018 |
| The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis S Tam, S Fu, L Xu, KJ Krause, DR Lairson, H Miao, EM Sturgis, ... Oral oncology 82, 91-99, 2018 | 110 | 2018 |
| National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia RF Harrison, W He, S Fu, H Zhao, CC Sun, RS Suidan, TL Woodard, ... American journal of obstetrics and gynecology 221 (5), 474. e1-474. e11, 2019 | 46 | 2019 |
| Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: a comparative study between Texas and National SEER areas S Fu, M Wang, DR Lairson, R Li, B Zhao, XL Du Oncotarget 8 (68), 112516, 2017 | 42 | 2017 |
| Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta‐analysis of observational studies H Tang, S Fu, S Zhai, Y Song, MM Asgari, J Han Pharmacoepidemiology and Drug Safety 27 (3), 279-288, 2018 | 38 | 2018 |
| Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas DR Lairson, S Fu, W Chan, L Xu, Z Shelal, L Ramondetta Gynecologic oncology 145 (1), 108-113, 2017 | 34 | 2017 |
| Use of antihypertensive drugs and risk of malignant melanoma: a meta-analysis of observational studies H Tang, S Fu, S Zhai, Y Song, J Han Drug safety 41, 161-169, 2018 | 28 | 2018 |
| Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis. JAMA Oncol. 2017; 3 (7): e170580 DA Berry, S Zhou, H Higley, L Mukundan, S Fu, GH Reaman This meta-analysis demonstrates the prognostic significance of MRD …, 2017 | 22 | 2017 |
| Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery KL Corrigan, S Fu, YS Chen, K Kaiser, M Roth, SK Peterson, YCT Shih, ... Cancer 128 (13), 2455-2462, 2022 | 20 | 2022 |
| Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis J Rodriguez, JA Rauh-Hain, J Saenz, DO Isla, GJR Pereira, D Odetto, ... International Journal of Gynecologic Cancer 31 (4), 2021 | 20 | 2021 |
| Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas S Fu, DR Lairson, W Chan, CF Wu, L Ramondetta Gynecologic oncology 148 (2), 342-348, 2018 | 20 | 2018 |
| Phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis H Tang, W Wu, S Fu, S Zhai, Y Song, J Han Journal of the American Academy of Dermatology 77 (3), 480-488. e9, 2017 | 18 | 2017 |
| Cost effectiveness of transplant, conventional chemotherapy, and novel agents in multiple myeloma: a systematic review S Fu, CF Wu, M Wang, DR Lairson Pharmacoeconomics 37, 1421-1449, 2019 | 16 | 2019 |
| Work outcomes after intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for oropharyngeal cancer GL Smith, S Fu, MS Ning, DK Nguyen, PM Busse, RL Foote, AS Garden, ... International journal of particle therapy 8 (1), 319-327, 2021 | 15 | 2021 |
| National trends in bowel and upper abdominal procedures in ovarian cancer surgery JA Dottino, W He, CC Sun, H Zhao, S Fu, JA Rauh-Hain, RS Suidan, ... International Journal of Gynecologic Cancer 30 (8), 2020 | 14 | 2020 |
| Patient cost sharing during poly (adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer RF Harrison, S Fu, CC Sun, H Zhao, KH Lu, SH Giordano, LA Meyer American journal of obstetrics and gynecology 225 (1), 68. e1-68. e11, 2021 | 13 | 2021 |
| Costs of cancer care for elderly patients with neuroendocrine tumors C Shen, A Dasari, D Gu, Y Chu, S Zhou, Y Xu, D Halperin, S Fu, JC Yao, ... Pharmacoeconomics 36, 1005-1013, 2018 | 13 | 2018 |
| Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States SP Huepenbecker, CC Sun, S Fu, H Zhao, K Primm, SH Giordano, ... Cancer 127 (22), 4151-4160, 2021 | 12 | 2021 |
| Sensitivity of psychosocial distress screening to identify cancer patients at risk for financial hardship during care delivery JA Maldonado, S Fu, YS Chen, C Acquati, KR Yabroff, MP Banegas, ... JCO Oncology Practice 17 (12), e1856-e1865, 2021 | 11 | 2021 |
